{"id":251450,"date":"2012-02-18T03:19:33","date_gmt":"2012-02-18T03:19:33","guid":{"rendered":"http:\/\/www.eugenesis.com\/aegon-profit-falls-on-charges-shares-rise-on-longevity-swap\/"},"modified":"2012-02-18T03:19:33","modified_gmt":"2012-02-18T03:19:33","slug":"aegon-profit-falls-on-charges-shares-rise-on-longevity-swap","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity\/aegon-profit-falls-on-charges-shares-rise-on-longevity-swap.php","title":{"rendered":"Aegon Profit Falls on Charges; Shares Rise on Longevity Swap"},"content":{"rendered":"<p>February 17, 2012, 5:44 PM  EST  <\/p>\n<p class=\"partner\">    By Maud van Gaal  <\/p>\n<p>    (Updates to add longevity swap and analyst comments, starting    in third paragraph.)  <\/p>\n<p class=\"indent\">    Feb. 17 (Bloomberg) -- Aegon NV, the Dutch owner of U.S.    insurer Transamerica Corp., reported a 75 percent decline in    fourth-quarter profit on reorganization costs and lower    investment returns from equity markets and interest rates.  <\/p>\n<p class=\"indent\">    Net income fell to 79 million euros ($106 million) from 318    million euros a year earlier, the Hague-based insurer said    today. The firm had 194 million euros in charges, including 48    million euros related to U.K. insurance policies.  <\/p>\n<p class=\"indent\">    The shares rose as the insurer said it completed a swap with    Deutsche Bank AG to protect the firm against the risk of    pensioners living longer than expected. Aegon, which makes most    of its profit in the U.S., repeated that it aims to increase    underlying pretax profit by 7 percent to 10 percent a year on    average until 2015 and to post a return on equity of 10 percent    to 12 percent.  <\/p>\n<p class=\"indent\">    \u201cIt\u2019s positive that longevity risk has been reduced in the    Dutch book,\u201d Albert Ploegh, an Amsterdam-based analyst at ING    Groep NV, wrote in a note today. \u201cAfter several insurers had to    take charges on the back of increased longevity, Aegon now    appears to have tackled this issue.\u201d  <\/p>\n<p class=\"indent\">    Shares of Aegon, whose Pyramid building is a landmark in San    Francisco\u2019s financial district, jumped as much as 7 percent in    Amsterdam today. They were up 6.3 percent to 3.97 euros at    11:50 a.m. local time, giving the company a market value of 7.6    billion euros. That outpaced the 1.1 percent advance in the 28-    company Bloomberg Europe 500 Insurance Index.  <\/p>\n<p class=\"center\">    No Acquisitions  <\/p>\n<p class=\"indent\">    Aegon doesn\u2019t plan a share buyback or acquisitions at this    point, Chief Executive Officer Alex Wynaendts told analysts on    a conference call today. He plans to continue a strategy of    maintaining a strong capital position as market volatility will    likely persist in coming years, even as the \u201cbottom of the euro    crisis is probably behind us.\u201d  <\/p>\n<p class=\"indent\">    Profit missed the average estimate of 209 million euros in a    Bloomberg survey of 10 analysts. Aegon said today it proposed a    2011 dividend of 10 cents per share, as the company had    previously indicated. It would be the company\u2019s first payout    since 2008, when it took state aid during the financial crisis.  <\/p>\n<p class=\"indent\">    \u201cThe fourth-quarter result was mainly affected by one-off    charges which we do not expect to occur in 2012,\u201d Lemer Salah,    an Amsterdam-based analyst at SNS Securities, said in a note.    \u201cWe believe that the company is well positioned to achieve its    objectives in the U.S. and Netherlands.\u201d  <\/p>\n<p class=\"center\">    Longevity Swap  <\/p>\n<p class=\"indent\">    Wynaendts said Aegon may do more transactions like today\u2019s    longevity swap, which will see Deutsche Bank protect 12 billion    euros, or one-third of the reserves in the Dutch business. \u201cThe    transaction reduces required capital at an attractive cost,\u201d    Aegon said.  <\/p>\n<p class=\"indent\">    The risk of pensioners living longer will be borne by investors    rather than Deutsche Bank, the German bank said in a separate    statement. It is the first transaction to place such risk    wholly in the capital markets, it said.  <\/p>\n<p class=\"indent\">    In 2011, Aegon set aside 82 million euros to cover life-    expectancy risks in the Netherlands, Wynaendts said in an    interview today. The transaction today helps the insurer    increase its capacity on the Dutch pension market.  <\/p>\n<p class=\"indent\">    Aegon\u2019s value of new business, a measure of projected future    profitability of new policies, fell 59 percent to 53 million    euros in the fourth quarter. That is unsurprising given \u201cthe    historic low interest rates\u201d in the insurer\u2019s key markets,    Wynaendts told reporters on the call.  <\/p>\n<p class=\"center\">    U.K., Dutch Charges  <\/p>\n<p class=\"indent\">    Underlying pretax profit, which excludes investment swings,    fell 23 percent to 346 million euros, almost matching the    average estimate of 347 million euros in a Bloomberg survey of    12 analysts. Earnings on this basis fell 17 percent in 2011.  <\/p>\n<p class=\"indent\">    In the Netherlands, Aegon wrote down 75 million euros on its    distribution business in anticipation of a ban on commissions    in life and pension products starting in 2013, Wynaendts said.    The U.K. charges, which were related to fixing administrative    errors, exceeded the estimate of Cor Kluis, an analyst at    Rabobank International.  <\/p>\n<p class=\"indent\">    \u201cWith all these charges for the U.K. taken, the year 2012    should be a normal profit level,\u201d Kluis, based in Utrecht, the    Netherlands, said in a note.  <\/p>\n<p class=\"indent\">    Aegon\u2019s profit goals rely on assumptions including a 4.75    percent U.S. 10-year bond yield for 2016, which is more than    double the current 2 percent rate.  <\/p>\n<p class=\"indent\">    The U.S. Federal Reserve said last month that it sees    \u201cexceptionally low\u201d interest rates through 2014, having    previously pledged to refrain from raising borrowing costs    until at least the middle of 2013. Insurers suffer from lower    long- term interest rates as they hold back returns from bond    investments and increase future liabilities.  <\/p>\n<p>    --With assistance from Martijn van der Starre in Amsterdam and    Kevin Crowley in London. Editors: Keith Campbell, Steve Bailey.  <\/p>\n<p>    To contact the reporter on this story: Maud van Gaal in    Amsterdam at <a href=\"mailto:mvangaal@bloomberg.net\">mvangaal@bloomberg.net<\/a>  <\/p>\n<p>    To contact the editor responsible for this story: Frank    Connelly at <a href=\"mailto:fconnelly@bloomberg.net\">fconnelly@bloomberg.net<\/a>  <\/p>\n<\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.businessweek.com\/news\/2012-02-17\/aegon-profit-falls-on-charges-shares-rise-on-longevity-swap.html\" title=\"Aegon Profit Falls on Charges; Shares Rise on Longevity Swap\">Aegon Profit Falls on Charges; Shares Rise on Longevity Swap<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>February 17, 2012, 5:44 PM EST By Maud van Gaal (Updates to add longevity swap and analyst comments, starting in third paragraph.) Feb. 17 (Bloomberg) -- Aegon NV, the Dutch owner of U.S <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/longevity\/aegon-profit-falls-on-charges-shares-rise-on-longevity-swap.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577495],"tags":[],"class_list":["post-251450","post","type-post","status-publish","format-standard","hentry","category-longevity"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251450"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=251450"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/251450\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=251450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=251450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=251450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}